Vol. 60 No. 4 (2021): Acta Oncologica

Articles

• Comment on ‘Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab’

  Mehmet Zahid Kocak

  564-565

  Published: 2021-04-03

  • PDF

• Taxane-induced pain in breast cancer patients as perceived by nurses

  Susanne Hellerstedt-Börjesson, Karin Nordin, Marie-Louise Fjällskog, Magnus Peterson, Cecilia Arving

  412-418

  Published: 2021-04-03

  • PDF

• Identification of endometrial cancer recurrence – a validated algorithm based on nationwide Danish registries

  Linda A. Rasmussen, Henry Jensen, Line F. Virgilsen, Mette M. Jeppesen, Jan Blaakaer, Dorte G. Hansen, Pernille T. Jensen, Ole Mogensen, Peter Vedsted

  452-458

  Published: 2021-04-03

  • PDF

• Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study

  Jakob Schmidt Jensen, Kathrine Kronberg Jakobsen, Christian Mirian, Mustafa Ghanizada, Katrin Håkansson, Irene Wessel, Christian Grønhøj, Jacob Høygaard Rasmussen, Christian von Buchwald

  491-496

  Published: 2021-04-03

  • PDF

• Identification of a novel resistance mechanism in venetoclax treatment and its prediction in chronic lymphocytic leukemia

  Ferenc Takács, Gábor Mikala, Noémi Nagy, Andrea Reszegi, Ágnes Czeti, Gábor Szalóki, Gábor Barna

  528-530

  Published: 2021-04-03

  • PDF

• Prognostic role of TLR4 and TLR2 in hepatocellular carcinoma

  Valtteri Kairaluoma, Niko Kemi, Heikki Huhta, Vesa-Matti Pohjanen, Olli Helminen

  554-558

  Published: 2021-04-03

  • PDF

• Look at the compass needle and see your course – navigation as a cancer survivor

  Christoffer Johansen, Susanne O. Dalton

  401-402

  Published: 2021-04-03

  • PDF

• The PROMova study comparing active and passive use of patient-reported outcome measures in ovarian cancer follow-up: effect on patient-perceived involvement, satisfaction with care, and usefulness

  Anette Stolberg Kargo, Pernille Tine Jensen, Kristina Lindemann, Niels Henrik Ingvar Hjollund, Bente Lund, Mette Haee, Sören Möller, Dorte Gilså Hansen, Karina Dahl Steffensen

  434-443

  Published: 2021-04-03

  • PDF

• Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab

  Anton E. Andersson, Barbro Linderholm, Daniel Giglio

  475-481

  Published: 2021-04-03

  • PDF

• Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS)

  Johannes Asplund, Eivind Gottlieb-Vedi, Wilhelm Leijonmarck, Fredrik Mattsson, Jesper Lagergren

  513-520

  Published: 2021-04-03

  • PDF

• Immune cell score, PD-L1 expression and prognosis in esophageal cancer

  Anna Junttila, Juha P. Väyrynen, Maarit Ahtiainen, Teijo Kuopio, Johanna Mrena, Eero Sihvo, Olli Helminen

  544-548

  Published: 2021-04-03

  • PDF

• Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment

  Dag Rune Stormoen, Christina Baeksted, Gry Assam Taarnhøj, Christoffer Johansen, Helle Pappot

  419-425

  Published: 2021-04-03

  • PDF

• Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

  Gincy George, Hanna Vikman, Rolf Gedeborg, Ingela Franck Lissbrant, Hans Garmo, Johan Styrke, Mieke Van Hemelrijck, Pär Stattin

  459-465

  Published: 2021-04-03

  • PDF

• Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study

  Ali Al-Kaabi, Rachel S. van der Post, Leonie R. van der Werf, Bas P. L. Wijnhoven, Camiel Rosman, Maarten C. C. M. Hulshof, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven, Peter D. Siersema

  497-504

  Published: 2021-04-03

  • PDF

• PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

  Maysaa Abdulla, Andrei Alexsson, Christer Sundström, Claes Ladenvall, Larry Mansouri, Cecilia Lindskog, Mattias Berglund, Lucia Cavelier, Gunilla Enblad, Peter Hollander, Rose-Marie Amini

  531-538

  Published: 2021-04-03

  • PDF

• Spectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community

  Tracy Ngo, Claudia Hossain, Anthony K. Guzman, Balazs Halmos, Yevgeniy Balagula, Beth McLellan

  559-563

  Published: 2021-04-03

  • PDF

• The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?

  A. van der Hout, K. Holtmaat, F. Jansen, B. I. Lissenberg-Witte, C. F. van Uden-Kraan, G. A. P. Nieuwenhuijzen, J. A. Hardillo, R. J. Baatenburg de Jong, N. L. Tiren-Verbeet, D. W. Sommeijer, K. de Heer, C. G. Schaar, R. J. E. Sedee, K. Bosscha, M. W. M. van den Brekel, J. F. Petersen, M. Westerman, J. Honings, R. P. Takes, I. Houtenbos, W. T. van den Broek, R. de Bree, P. Jansen, S. E. J. Eerenstein, C. R. Leemans, J. M. Zijlstra, P. Cuijpers, L. V. van de Poll-Franse, I. M. Verdonck-de Leeuw

  403-411

  Published: 2021-04-03

  • PDF

• Management of low-grade cervical cytology in young women. Cohort study from Denmark

  Gry St-Martin, Lise Holst Thamsborg, Berit Andersen, Jette Christensen, Dorthe Ejersbo, Kirsten Jochumsen, Tonje Johansen, Lise Grupe Larsen, Marianne Waldstrøm, Elsebeth Lynge

  444-451

  Published: 2021-04-03

  • PDF

• Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohort

  Siavash Foroughi, Hui-li Wong, Jeanne Tie, Rachel Wong, Margaret Lee, Belinda Lee, Ian Jones, Iain Skinner, Antony W. Burgess, Peter Gibbs

  482-490

  Published: 2021-04-03

  • PDF

• Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting

  Thomas Ringgaard Petersen, Vasiliki Panou, Christos Meristoudis, Ulla Møller Weinreich, Oluf Dimitri Røe

  521-527

  Published: 2021-04-03

  • PDF

• Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer

  Giacomo Bregni, Caroline Vandeputte, Andrea Pretta, Chiara Senti, Elena Trevisi, Elena Acedo Reina, Pashalina Kehagias, Gabriel Liberale, Luigi Moretti, Maria Antonietta Bali, Pieter Demetter, Patrick Flamen, Javier Carrasco, Lionel D'Hondt, Karen Geboes, Yeter Gokburun, Marc Peeters, Marc Van den Eynde, Jean-Luc Van Laethem, Philippe Vergauwe, Camille Anastasia Chapot, Marc Buyse, Amelie Deleporte, Alain Hendlisz, Francesco Sclafani

  549-553

  Published: 2021-04-03

  • PDF

• Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?

  J. Skalleberg, M. Myhrum, M. C. Småstuen, T. A. Osnes, S. D. Fosså, M. Bunne

  426-433

  Published: 2021-04-03

  • PDF

• Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide

  Patrice Chevallier, Ana Berceanu, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Berthe-Marie Imbert, Etienne Daguindau, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Anne Lok, Benoît Tessoulin, Sophie Vantyghem, Yohan Desbrosses, Céline Bressollette, Alix Duquesne, Marion Eveillard, Yannick Le Bris, Anne Dormoy, Caroline Malugani, Eric Deconinck, Philippe Moreau, Steven Le Gouill, Marie C. Béné, Thierry Guillaume

  466-474

  Published: 2021-04-03

  • PDF

• Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients

  Animesh Saha, Matthew Beasley, Nathaniel Hatton, Peter Dickinson, Kevin Franks, Katy Clarke, Pooja Jain, Mark Teo, Patrick Murray, John Lilley

  505-512

  Published: 2021-04-03

  • PDF

• Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

  Midas B. Mulder, Erwin Birnie, Caroline van Dijck – van Boetzelaer, Gert-Jan van de Geijn, Egbert Boevé, Elsbeth M. Westerman, Paul Hamberg

  539-543

  Published: 2021-04-03

  • PDF